Evidence map›Paper›PMID 17043127›Full record

ArticleAntimicrobial agents and chemotherapy2007

Characterization of squalene epoxidase of Saccharomyces cerevisiae by applying terbinafine-sensitive variants.

Christoph Ruckenstuhl, Silvia Lang, Andrea Poschenel, Armin Eidenberger, Pravas Kumar Baral, Peter Kohút, Ivan Hapala, Karl Gruber, Friederike Turnowsky

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Integrating Machine Learning and Molecular Methods forPathogens (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Microbiology spectrum · 2023
    Article
  5. Article
  6. Construction and Optimization of theFrontiers in bioengineering and biotechnology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Emerging Terbinafine Resistance inAntimicrobial agents and chemotherapy · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Christoph RuckenstuhlInstitute of Molecular Biosciences, Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria.
Silvia Lang
Andrea Poschenel
Armin Eidenberger
Pravas Kumar Baral
Peter Kohút
Ivan Hapala
Karl Gruber
Friederike Turnowsky
University of Graz · ATInstitute of Animal Biochemistry and Genetics · SKSlovak Academy of Sciences · SK

Funding

Austrian Science Fund FWF W 901
6 · The paper itself

Abstract

Squalene epoxidase (SE) is the target of terbinafine, which specifically inhibits the fungal enzyme in a noncompetitive manner. On the basis of functional homologies to p-hydroxybenzoate hydroxylase (PHBH) from Pseudomonas fluorescens, the Erg1 protein contains two flavin adenine dinucleotide (FAD) domains and one nucleotide binding (NB) site. By in vitro mutagenesis of the ERG1 gene, which codes for the Saccharomyces cerevisiae SE, we isolated erg1 alleles that conferred increased terbinafine sensitivity or that showed a lethal phenotype when they were expressed in erg1-knockout strain KLN1. All but one of the amino acid substitutions affected conserved FAD/nucleotide binding sites. The G(25)S, D(335)X (W, F, P), and G(210)A substitutions in the FADI, FADII, and NB sites, respectively, rendered the SE variants nonfunctional. The G(30)S and L(37)P variants exhibited decreased enzymatic activity, accompanied by a sevenfold increase in erg1 mRNA levels and an altered sterol composition, and rendered KLN1 more sensitive not only to allylamines (10 to 25 times) but also to other ergosterol biosynthesis inhibitors. The R(269)G variant exhibited moderately reduced SE activity and a 5- to 10-fold increase in allylamine sensitivity but no cross-sensitivity to the other ergosterol biosynthesis inhibitors. To further elucidate the roles of specific amino acids in SE function and inhibitor interaction, a homology model of Erg1p was built on the basis of the crystal structure of PHBH. All experimental data obtained with the sensitive Erg1 variants support this model. In addition, the amino acids responsible for terbinafine resistance, although they are distributed along the sequence of Erg1p, cluster on the surface of the Erg1p model, giving rise to a putative binding site for allylamines.

Indexed as

AllelesAllylamineAmino Acid SubstitutionAntifungal AgentsDrug Resistance, FungalFlavin-Adenine DinucleotideNaphthalenesProtein BindingProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSqualene MonooxygenaseSterolsStructure-Activity RelationshipTemperatureTerbinafineAllylamineAntifungal AgentsFlavin-Adenine DinucleotideNaphthalenesSaccharomyces cerevisiae ProteinsSqualene MonooxygenaseSterolsTerbinafine

Identifiers

PMID17043127
PMCPMC1797698
OpenAlexW2171339512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.